Improving Clinical Quality in Womens Health Screenings and

  • Slides: 39
Download presentation
Improving Clinical Quality in Women's Health Screenings and Beyond Kentucky Primary Care Association Spring

Improving Clinical Quality in Women's Health Screenings and Beyond Kentucky Primary Care Association Spring Conference Anne Gaglioti, MD SERCN Director Assistant Professor of Family Medicine National Center for Primary Care Morehouse School of Medicine May 9, 2017 Funding Acknowledgement: This program was funded through a Patient-Centered Outcomes Research Institute (PCORI) Eugene Washington PCORI Engagement Award (EAIN-3315).

Vision: National Resource to Achieve Equitable and Optimal Health Through Primary Care For All.

Vision: National Resource to Achieve Equitable and Optimal Health Through Primary Care For All. Mission: Strengthening the Primary Care System through Research, Education, and Training To improve Health Outcomes while Advancing and Sustaining Health Equity

Community Health Practice & Population Based Health Equity Research Policy Health Information Technology Quality

Community Health Practice & Population Based Health Equity Research Policy Health Information Technology Quality Improvement Education and Training Primary Care

Southeast Regional Clinicians Network • Practice Based Research Network (PBRN) • Our GOAL: –

Southeast Regional Clinicians Network • Practice Based Research Network (PBRN) • Our GOAL: – to improve quality of care and outcomes to medically underserved patients in the Southeastern United States. • Our MEMBERS: – federally qualified health centers and state primary care associations located in the states of Alabama, Florida, Georgia, Kentucky, , Mississippi, North Carolina, South Carolina and Tennessee • Our HISTORY: – Partnership between the National Center for Primary Care and the Southeast Health Care Consortium – Funded as a PBRN by AHRQ in 1995

Objectives • Screening women throughout the lifecycle • Streamline despite differing intervals • Checklists,

Objectives • Screening women throughout the lifecycle • Streamline despite differing intervals • Checklists, Templates, Resources • Data Collection and Evaluation The Family Doctor, Grant Wood (American 1892 -1942)

Why this is Difficult “To fully satisfy the USPSTF recommendations, 1773 hours of a

Why this is Difficult “To fully satisfy the USPSTF recommendations, 1773 hours of a physicians annual time, or 7. 4 hours per working day, is needed for the provision of preventive services. ”

Well Exam?

Well Exam?

Screening Women Across the Lifecycle

Screening Women Across the Lifecycle

Uniform Data System Measures for Women’s Health Screening • Cervical Cancer Screening – Proportion

Uniform Data System Measures for Women’s Health Screening • Cervical Cancer Screening – Proportion of women ages 21 -64 with a PAP smear in the last 3 years • Colorectal Cancer Screening – Proportion 50 through 75 years with a CRC screening test • BMI Screening • Tobacco Screening • Depression Screening

Healthy People 2020 Goals and USPSTF

Healthy People 2020 Goals and USPSTF

What Improves Screening in Safety Net Settings? • For Cancer Screening Generally – Patient

What Improves Screening in Safety Net Settings? • For Cancer Screening Generally – Patient reminders, small media, and provider audit and feedback • For Breast cancer screening – Reducing out of pocket costs • For CRC and breast cancer screening – Reducing structural barriers

The Power of Checklists

The Power of Checklists

Screening Women Across the Lifecycle Recommendations by Different Age Groups and Risk Factors •

Screening Women Across the Lifecycle Recommendations by Different Age Groups and Risk Factors • Focus on Key Screening Tests • Highlight differences across the lifecycle

Screening Women Across the Lifecycle

Screening Women Across the Lifecycle

Screening Women Across the Lifecycle: Cervical Cancer • Cervical Cancer Screening: – Start at

Screening Women Across the Lifecycle: Cervical Cancer • Cervical Cancer Screening: – Start at 21 – Every 3 years; reflex High risk HPV testing – At age 30, HPV co-testing every 5 years if desired – Stop at age 65 if 2 previous PAPs normal and normal risk

Screening Women Across the Lifecycle: Breast Cancer • USPSTF: – Ages 40 -49: Individualize

Screening Women Across the Lifecycle: Breast Cancer • USPSTF: – Ages 40 -49: Individualize decision to begin biennial screening according to the patient’s circumstances and values (C) – Ages 50 -75: screen every two years (B) – Ages >75 : no recommendation due to insufficient evidence – Recommends against BSE (D) – Insufficient evidence for or against CBE (I)

Screening Women Across the Lifecycle: Breast Cancer • American Cancer Society: – Stop after

Screening Women Across the Lifecycle: Breast Cancer • American Cancer Society: – Stop after <10 years life expectancy – No CBE/BSE

Screening Women Across the Lifecycle: Breast Cancer • Assessing Risk for Breast Cancer –

Screening Women Across the Lifecycle: Breast Cancer • Assessing Risk for Breast Cancer – Gail Model

Screening Women Across the Lifecycle: Lung Cancer • Screen ages 55 -80 with history

Screening Women Across the Lifecycle: Lung Cancer • Screen ages 55 -80 with history of smoking using low dose CT – 30 pack years – Currently smoking or quit 15 years ago or less • Interval: yearly • Stop: 15 years since quit date, other life-limiting disease, or lack of willingness to have curative lung surgery

Screening Women Across the Lifecycle: Colorectal Cancer • Screen women ages 50 -75 •

Screening Women Across the Lifecycle: Colorectal Cancer • Screen women ages 50 -75 • Ability to obtain colonoscopy testing if stool testing positive

Screening Women Across the Lifecycle: Diabetes • Screen at any age if hypertensive or

Screening Women Across the Lifecycle: Diabetes • Screen at any age if hypertensive or elevated BP above 135/85 • Screen ages 40 -70 if BMI is in the overweight or obese range • Interval : 3 years

Screening Women Across the Lifecycle: Statins • USPSTF: Women ages 40 -75 without CVD

Screening Women Across the Lifecycle: Statins • USPSTF: Women ages 40 -75 without CVD who have: – One or more CVD risk factor: dyslipidemia, smoking, diabetes – A CVD risk of 10% or greater in the next 10 years (B) – CVD risk of 7. 5% or greater in the next 10 years (C)

Screening Women Across the Lifecycle: Statins • Interval: (AHA) screen individuals over age 20

Screening Women Across the Lifecycle: Statins • Interval: (AHA) screen individuals over age 20 without risk factors every 4 -6 years

Screening Women Across the Lifecycle: Depression • Screen general adult population including pregnant/postpartum women

Screening Women Across the Lifecycle: Depression • Screen general adult population including pregnant/postpartum women using validated screening tool with adequate systems for diagnosis and referral to treatment • Interval: yearly/ using clinical judgment • Tools: PHQ-2/9; Beck Depression Inventory; Edinburgh Postnatal Depression Scale

Screening Women Across the Lifecycle: Alcohol Use • Screen adults ages 18 and over

Screening Women Across the Lifecycle: Alcohol Use • Screen adults ages 18 and over for alcohol misuse • Tools: AUDIT, single question screen “How many times in the last year have you had more than 4 drinks on one occasion? ” • Interval: yearly or in high risk settings

Screening Women Across the Lifecycle: Intimate Partner Violence • Screen women of childbearing age

Screening Women Across the Lifecycle: Intimate Partner Violence • Screen women of childbearing age for IPV and refer those who screen positive to intervention services (B) • Screening Tools: HITS English/Spanish • Interval: no evidence

Screening Women Across the Lifecycle: Sexually Transmitted Infections • HIV: ages 15 -65 –

Screening Women Across the Lifecycle: Sexually Transmitted Infections • HIV: ages 15 -65 – Interval USPSTF: very high risk annual, increased risk 3 -5 years, low risk once • CDC yearly • Gonorrhea/Chlamydia: – ages <24 routine screening – ages >24 with risk factors • Syphilis: screen all adults and adolescents at risk – MSM, commercial sex workers, incarceration, geography

Screening Women Across the Lifecycle: Hepatitis C • Screen adults born in 1945 -1965

Screening Women Across the Lifecycle: Hepatitis C • Screen adults born in 1945 -1965 for Hepatitis C once

Resources for Women’s Screening Checklists Office of Women’s Health

Resources for Women’s Screening Checklists Office of Women’s Health

Resources for Women’s Screening Checklists • AHRQ e. PSS tool

Resources for Women’s Screening Checklists • AHRQ e. PSS tool

Operationalize a Women’s Health Screening Checklist • • Construct as a team Designate pre-visit

Operationalize a Women’s Health Screening Checklist • • Construct as a team Designate pre-visit Designate during-visit Consider embedding in note

Operationalize a Women’s Health Screening Checklist • Pre-visit with MA or paper forms –

Operationalize a Women’s Health Screening Checklist • Pre-visit with MA or paper forms – Depression – AUDIT – HITS – BMI – BP

Operationalize a Women’s Health Screening Checklist • Embed Table/List in note that includes –

Operationalize a Women’s Health Screening Checklist • Embed Table/List in note that includes – Recommendation – Completed – Due date

Operationalize a Women’s Health Screening Checklist Recommendation Breast Cancer Screening (biannual, ages 50 -75)

Operationalize a Women’s Health Screening Checklist Recommendation Breast Cancer Screening (biannual, ages 50 -75) Cervical Cancer Screening (q 3 -5 years, ages 21 -65) Lung Cancer Screening (yearly, 30 pack years, ages 55 -80) CRC Screening (q 1 -10 years, ages 50 -75) Statin Indicated based on risk factors (40 -70 with risk factors, increased cvd risk 10/7. 5%)* ASA Diabetes with Ha 1 C (q 3 years, BMI/ BP ages 40 -70) Hepatitis C (once, those born 1945 -1965) HIV (interval based on risk, ages 15 -65) GC/CT (routine <24; increased risk >24) Completed/Result Due

A Word About Evaluation and QI • You can’t know if you don’t look

A Word About Evaluation and QI • You can’t know if you don’t look • Promote Equity

What Questions do you Have? Anne Gaglioti: agaglioti@msm. edu NCPC Website: www. primarycarematters. org

What Questions do you Have? Anne Gaglioti: agaglioti@msm. edu NCPC Website: www. primarycarematters. org SERCN Email: sercn@msm. edu SERCN Website: www. sercn. org Twitter: @sercn_ncpc

References • Kimberly S. H. Yarnall, Kathryn I. Pollak, Truls Østbye, Katrina M. Krause,

References • Kimberly S. H. Yarnall, Kathryn I. Pollak, Truls Østbye, Katrina M. Krause, and J. Lloyd Michener. Primary Care: Is There Enough Time for Prevention? American Journal of Public Health April 2003: Vol. 93, No. 4, pp. 635 -641. • Brouwers MC, De Vito C, Bahirathan L, et al. What implementation interventions increase cancer screening rates? a systematic review. Implementation Science  IS. 2011; 6: 111. doi: 10. 1186/1748 -5908 -6 -111. • Sabatino SA, Lawrence B, Elder R, Mercer SL, Wilson KM, De. Vinney B, Melillo S, Carvalho M, Taplin S, Bastani R, Rimer BK. Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services. American journal of preventive medicine. 2012 Jul 31; 43(1): 97 -118 • Ely JW, Graber ML, Croskerry P. Checklists to reduce diagnostic errors. Academic Medicine. 2011 Mar 1; 86(3): 307 -13.